Genetic screening in Parkinson*s Disease in order to identify patients who can participate in clinical trials with new targeted therapies

Completed

• Conditions: movement disorder; Parkinson's disease; 10028037

• Registration Number: NL-OMON45734
• Lead Sponsor: Centre for Human Drug Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 1000

Inclusion Criteria

1. Signed informed consent prior to any study-mandated procedure;
2. Diagnosis of Parkinson*s Disease, diagnosed by a neurologist;
3. Has the ability to communicate well with the Investigator in the Dutch language and willing to comply with the study restrictions.

Exclusion Criteria

N/A

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Sequence of the GBA1 gene<br /><br>Presence of 7 specific mutations in the LRRK2 gene</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Database of genotyped PD patients, for future research on PD</p><br>